Clinical trial to evaluate the safety and immunogenicity of a trivalent surface antigen seasonal influenza vaccine produced in mammalian cell culture and administered to young and elderly adults with and without A(H1N1) pre-vaccination.

Clinical trial to evaluate the safety and immunogenicity of a trivalent surface antigen seasonal influenza vaccine produced in mammalian cell culture and administered to young and elderly adults with and without A(H1N1) pre-vaccination.

<h4>Unlabelled</h4>Vaccination against influenza is an important means of reducing morbidity and mortality in subjects at risk. The prevalent viral strains responsible for seasonal epidemics usually change annually, but the WHO recommendations for the 2011/2012-season in the Northern hem...

Full description

Bibliographic Details
Main Authors: Micha Loebermann, Ulrich Voss, Seetha Meyer, Dietrich Bosse, Carlos Fritzsche, Sebastian Klammt, Silvius Frimmel, Diana Riebold, Emil C Reisinger
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23976960/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23976960/?tool=EBI

Similar Items